Pubblicazioni ufficiali TME Pharma N.V.

Azioni

Mercato chiuso - Euronext Paris Altri mercati azionari 17:35:15 31/05/2024			Variaz. 5gg	Var. 1 gen.
0,258 ^EUR	+3,41%		+3,20%	+12,17%

25/04	TME Pharma N.V. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
23/04	TME Pharma N.V. annuncia che il 33% dei pazienti che ricevono NOX-A12 in combinazione con Bevacizumab e radioterapia raggiungono la sopravvivenza a due anni nello studio GLORIA di Fase 1/2 nel tumore al cervello	CI

Extraordinary general shareholder meeting	16/05/22	CO
Extraordinary general shareholder meeting	16/05/22	CO
Extraordinary general shareholder meeting	16/05/22	CO
Annual Report	22/04/22	CO
Annual results	22/04/22	CO
Annual results	22/04/22	CO
Annual results	22/04/22	CO
Minutes of the general assembly	15/12/21	CO
Minutes of the general assembly	15/12/21	CO
Minutes of the general assembly	15/12/21	CO
Half-year report	22/10/21	CO
1st-half-year results	22/10/21	CO
1st-half-year results	22/10/21	CO
1st-half-year results	22/10/21	CO
Changes in management and corporate officers	24/06/21	CO
Changes in management and corporate officers	24/06/21	CO
Changes in management and corporate officers	24/06/21	CO
Changes in management and corporate officers	08/02/21	CO
Changes in management and corporate officers	08/02/21	CO
Changes in management and corporate officers	08/02/21	CO
Changes in management and corporate officers	01/02/21	CO
Changes in management and corporate officers	01/02/21	CO
Changes in management and corporate officers	01/02/21	CO
Admission of new securities	26/01/21	CO
Admission of new securities	26/01/21	CO